ANSES
8
1
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Socioeconomic Determinants of the Chemical Exposome and Its Genotoxic Effects in Children
Role: collaborator
CRESPI - Respiratory Health of Children in Daycare
Role: collaborator
Environmental Exposures and Sudden Unexpected Infant Death
Role: collaborator
Impact of Environmental Exposures on Tumor Risk in SDHx-mutation Carriers
Role: collaborator
Identification of Occupational Exposures in Acute Hematologic Malignancy
Role: collaborator
Impact of Environmental Exposures on Tumor Risk in Subjects at Risk of Hereditary SDHx Paraganglioma
Role: collaborator
Anisakis Blastocystis Cryptosporidium Fish Serology
Role: collaborator
Anisakis Blastocystis Cryptosporidium Fish Prevalence
Role: collaborator
All 8 trials loaded